2 or 6
2000L XcellerexTM bioreactors
with associated downstream
new purification rooms
KBI is now offering commercial mammalian manufacturing through its North Carolina single-use facility expansion project.
Building on KBI’s legacy of being the first CMO in the world to implement the 2000L scale Xcellerex™ single-use bioreactor, the first stage of this commercial expansion effort is a commercial manufacturing suite equipped with an initial set of 3X 2000L Xcellerex™ bioreactors and a dedicated purification suite (3 purification rooms).
This commercial manufacturing suite and related equipment are flexible and take advantage of single-use technologies for each unit operation leveraging our extensive experience with large scale single-use equipment.
It will also be operated with strict adherence to regulations required for cGMP biopharmaceutical drug substance manufacturing.
The following additional capabilities were added as part of this expansion effort in support of this new commercial manufacturing suite: